TG Therapeutics Inc. (TGTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for TG Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$57.40
+1.70% today
Market cap
$8.6B
Overall quality
—
Kronos AI 30-day
−6.2%
1 of 8 simulated paths end higher
TG Therapeutics Inc. (TGTX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $8.6B. It trades at $57.40, up 1.70% today. 5 analysts' average target of $65.00 implies +13.2% from today's price. Kronos AI's 30-day forecast is −6.2% (1 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $65.00 |
| Low – high | $21.00 – $86.00 |
| Analysts | 5 |
| Upside to average | +13.2% |
Kronos AI 30-day forecast
| Expected close | $52.93 (−6.2%) |
| Likely range | −15.2% … −0.1% |
| As of | 2026-10-27 |
1 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.